Literature DB >> 11071021

Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.

T Hikichi1, J Akiyoshi, Y Yamamoto, T Tsutsumi, K Isogawa, H Nagayama.   

Abstract

In order to examine the involvement of corticotropin-releasing hormone (CRF) receptor in the formation of anxiety, we investigated whether CRF receptor antagonist CP-154,526 suppressed conditioned fear stress. First, rats were individually subjected to 30 min of footshock. Twenty-four hours after footshock, the rats were again placed in the chamber and observed for 5 min without shock. CP-154,526 was administered 30 min before placing the rats in the chamber again. After that, CP-154,526 was once more administered 30 min before applying footshock. Administration of CP-154,526 30 min both before conditioned fear stress (placing the rats inside the cage but not applying footshock) and before actual footshock significantly reduced freezing behavior. These results show that CP-154,526 blocked both the acquisition and expression of conditioned fear, thus suggesting that the CRF receptor might be related to anxiety.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11071021     DOI: 10.1055/s-2000-7587

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  16 in total

1.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Andrea Cippitelli; Lydia O Ayanwuyi; Estelle Barbier; Esi Domi; Jose M Lerma-Cabrera; Francisca Carvajal; Giulia Scuppa; Hongwu Li; Massimo Ubaldi; Markus Heilig; Marisa Roberto; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

2.  Effects of acute stress on acquisition of nicotine conditioned place preference in adolescent rats: a role for corticotropin-releasing factor 1 receptors.

Authors:  Jennifer Brielmaier; Craig G McDonald; Robert F Smith
Journal:  Psychopharmacology (Berl)       Date:  2011-07-01       Impact factor: 4.530

Review 3.  Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.

Authors:  Eric P Zorrilla; Markus Heilig; Harriet de Wit; Yavin Shaham
Journal:  Drug Alcohol Depend       Date:  2013-01-05       Impact factor: 4.492

Review 4.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

5.  Effects of CRF1 receptor antagonists and benzodiazepines in the Morris water maze and delayed non-matching to position tests.

Authors:  John B Hogan; Donald B Hodges; Snjezana Lelas; Paul J Gilligan; John F McElroy; Mark D Lindner
Journal:  Psychopharmacology (Berl)       Date:  2004-10-14       Impact factor: 4.530

Review 6.  Progress in corticotropin-releasing factor-1 antagonist development.

Authors:  Eric P Zorrilla; George F Koob
Journal:  Drug Discov Today       Date:  2010-03-03       Impact factor: 7.851

7.  Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression.

Authors:  Koichi Isogawa; David E A Bush; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

8.  Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Authors:  Fumikazu Yokoyama; Miki Yamauchi; Masayo Oyama; Kunihiro Okuma; Kaname Onozawa; Takako Nagayama; Rie Shinei; Makoto Ishikawa; Yasuo Sato; Nobukazu Kakui
Journal:  Psychopharmacology (Berl)       Date:  2009-04-09       Impact factor: 4.530

Review 9.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.

Authors:  C L Pickens; T Adams-Deutsch; S G Nair; B M Navarre; M Heilig; Y Shaham
Journal:  Neuroscience       Date:  2009-10-02       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.